Lower Risk of Death and Kidney Failure Associated with Higher Target (vs. Below-Target) Doses of RAS Inhibitors in Octogenarians with HFrEF
Related Posts
Chopard R, Hobohm L, Barco S, Bangalore S, Giri J, Mahfoud F, Moriarty J, Rosenkranz S, Sharp A, Thiele H, Toma C, Tapson VF, Markovitz[...]
Ahmed M, Abbas F, Khan S, Qureshi S, Khan GT, Shafiq SB, Imran W, Waqas SA, Fudim M, Fonarow GC, Greene SJ, Khan MS. Trends[...]
Xu H, Grory BCM, Ikeaba U, Alhanti B, Fonarow GC, Schwamm LH, Smith EE, Messe SR, Ostbye T, De Lemos JA, Peterson ED, Xian Y.[...]